Typical Daily Experiences, Ischemia and Repolarization in Coronary Artery Disease

NCT ID: NCT01531231

Last Updated: 2024-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

301 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-02

Study Completion Date

2016-03-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to examine the role of every day experiences as they relate to coronary artery disease (CAD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CAD is the most common setting in which sudden cardiac death (SCD) occurs. SCD is the leading cause of death in the U.S.

In this study we propose to test the following in patients with CAD:

* Determine whether experiences assessed randomly throughout the day are associated with changes in the blood supply to your heart muscle as measured by electrical recordings from your chest.
* Determine whether typical daily experiences are associated with changes in the recovery time portion of your heart beat cycle as measured by electrical recordings from your chest.
* Determine whether changes in the recovery time portion of your heart beat cycle associated with typical daily experiences occur exclusively with changes in the blood supply to your heart muscle.
* Determine whether typical daily experiences influences blood supply and recovery time based on the severity and presence of CAD (when comparing CAD patients to healthy subjects).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Behavioral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

YOUNG HEALTHY NO CORONARY ARTERY DISEASE

\- Whether an association between typical daily experiences and recovery time varies with age; this group will be compared to the older comparison group and to previous data collected from those subjects who participated in the Long QT Syndrome study (LQTS).

No interventions assigned to this group

OLDER HEALTHY NO CORONARY ARTERY DISEASE

\- Determine whether daily emotion influences ischemia and repolarization differentially as a function of the severity of CAD and presence of CAD when comparing CAD patients with healthy patients

No interventions assigned to this group

HIGH RISK CORONARY ARTERY DISEASE (CAD)

\- Determine whether emotion assessed randomly throughout the day is associated with myocardial ischemia

No interventions assigned to this group

LOW RISK CORONARY ARTERY DISEASE (CAD)

\- Determine whether typical daily emotion influences ischemia and repolarization differentially as a function of the severity of CAD and presence of CAD

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Proficient in English
* At least 21 years of age or older
* Stable coronary artery disease
* Willing to participant in 3 days of Holter monitor recordings and respond to surveys on a study provided smartphone


* Proficient in English
* 21 years of age or older
* Have stable coronary artery disease with a documented previous myocardial infarction
* Recent ECHO, MUGA or angiography (\< 5year old) reflecting a left-ventricular ejection fraction \<35%
* Single or dual chamber ICD, with a back up rate of ventricular pacing at \< 45 bpm
* Willing to wear a Holter monitor for 3 days and respond to surveys on a study provided smartphone


* Proficient in English
* 51 years of age or older
* No history and evidence of ischemic heart disease
* Normal screening ECG without evidence for rhythm abnormalities, conduction abnormalities, hypertrophy, or other pathologies
* Age matched within 5 years to CAD patients
* Negative treadmill/bicycle exercise test
* Willing to wear a Holter monitor for 3 days and respond to surveys on a study provided smartphone


* Proficient in English
* 21 to 50 years of age
* Normal screening ECG without evidence for rhythm abnormalities, conduction abnormalities, hypertrophy, or other pathologies
* Willing to wear a Holter monitor for 3 days and respond to surveys on a study provided smartphone

Exclusion Criteria

\- Presence of bundle branch block evident on ECG


* An implanted cardiac resynchronization pacemaker with ICD (CRT-D)
* Heart rhythm artificially continuously paced
* Presence of a bundle branch block evident on any ECG


* History of ischemic heart disease (CAD),prior myocardial infarction
* History of cardiac disease


* History of ischemic heart disease (CAD), prior myocardial infarction
* History of cardiac diseases
* Abnormal ECG
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rochester

OTHER

Sponsor Role collaborator

Richard Lane

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Richard Lane

MD, PhD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard D Lane, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Arizona

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arizona

Tucson, Arizona, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01HL103692-01A1

Identifier Type: NIH

Identifier Source: org_study_id

View Link